Eastwood Bio-Medical Canada Inc. (TSXV: EBM)

EBM Revenue

Eastwood Bio-Medical Canada had revenue of 188.26K CAD in the quarter ending July 31, 2024, with 0.67% growth. This brings the company's revenue in the last twelve months to 653.54K, down -41.64% year-over-year. In the fiscal year ending October 31, 2023, Eastwood Bio-Medical Canada had annual revenue of 867.94K, down -33.22%.

• Revenue (ttm): 653.54K
• Revenue Growth: -41.64%
• P/S Ratio: 71.68
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 46.84M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2023	867.94K	-431.83K	-33.22%
Oct 31, 2022	1.30M	318.71K	32.49%
Oct 31, 2021	981.05K	262.72K	36.57%
Oct 31, 2020	718.34K	-574.56K	-44.44%
Oct 31, 2019	1.29M	548.92K	73.78%